121050-01-9

Upstream product

• 3479-80-9 α,α'-dibromoglutaric acid 
• 100-51-6 benzyl alcohol 
• 108-55-4 glutaric anhydride, 
• 2873-74-7 gloutaric dichloride 
• 29548-85-4 2,4-dibromoglutaryl chloride 

Downstream Products

• 127310-69-4 cis-1-hexylazetidine-2,4-dicarboxylic acid dibenzyl ester 
• 127310-69-4 trans-1-hexylazetidine-2,4-dicarboxylic acid dibenzyl ester 
• 121050-02-0 cis-1-benzylazetidine-2,4-dicarboxylic acid dibenzyl ester 
• 121050-02-0 (±)-trans-dibenzyl 2,2'-(1-benzylazetidine-2,4-diyl)diacetate 
• 121050-12-2 cis-azetidine-2,4-dicarboxamide 
• 127310-66-1 ((2R,4S)-1-benzylazetidine-2,4-diyl)dimethanol 
• 127310-58-1 cis-1-benzylazetidine-2,4-dicarboxylic acid 
• 121050-14-4 1-benzyl-4-(hydroxymethyl)azetidine-2-carboxylic acid benzyl ester 
• 121050-04-2 (+/-)-cis-Azetidine diacid 
• 121050-03-1 trans-azetidine-2,4-dicarboxylic acid 
• 1400593-18-1 6-benzyl-3-cyclopropylcarbonyl-3,6-diazabicyclo[3.1.1]heptane 
• 1400593-11-4 C₇H₆O₂*C₉H₁₄N₂O 
• 1400593-12-5 C₉H₉NO₃*C₉H₁₄N₂O 

Relevant academic research and scientific papers

Synthesis and evaluation of novel azetidine analogs as potent inhibitors of vesicular [3H]dopamine uptake

Lobelane analogs that incorporate a central piperidine or pyrrolidine moiety have previously been reported by our group as potent inhibitors of VMAT2 function. Further central ring size reduction of the piperidine moiety in lobelane to a four-membered het

METHOD OF TREATMENT WITH 3-CYCLOPROPYLCARBONYL-3,6-DIAZABICYCLO[3.1.1]HEPTANE

The present invention relates to 3-cyclopropylcarbonyl-3,6-diazabicyclo[3.1.1]heptane, its salt forms, pharmaceutical compositions, and methods of treatment thereof.

SALT FORMS OF 3 - CYCLOPROPYLCARBONYL - 3, 6 - DIAZABICYCLO [3.1.1] HEPTANE

The present invention relates to 3-cyclopropylcarbonyl-3,6-diazabicyclo[3.1.1]heptane, its salt forms, and novel polymorphic forms of these salts.

Azetidine derivatives to treat memory and learning disorders

This invention relates to novel azetidines and derivatives thereof, as well as to pharmaceutical compositions and methods of treating memory and learning disorders. Another aspect of the invention relates to a method of utilizing the compounds and composi

Synthesis and Bioactivity of a New Class of Rigid Glutamate Analogues. Modulators of the N-Methyl-D-aspartate Receptor

A variety of derivatives of azetidine-2,4-dicarboxylic acid were synthesized and examined for their ability to stimulate 45Ca2+ uptake in cultures of cerebellar granule cells.Of the compounds tested, the cis-azetidine-2,4-dicarboxylic acid (10f

Azetidine derivatives, compositions and methods of treating

This invention relates to novel azetidines and derivative thereof, as well as to pharmaceutical compositions and methods of treating memory and learning disorders. Another aspect of the invention relates to a method of utilizing the compounds and compositions as biological tools and materials for characterizing excitatory amino acid receptor systems. A further aspect of the invention relates to a method of treating PCP toxicity and abuse.